Wegovy Pill and Mounjaro Comparison
Wegovy Pill vs Mounjaro: Which Is Better?
Quick answer: Neither treatment is automatically better for everyone. The Wegovy pill is oral semaglutide taken every day after an overnight fast, while Mounjaro is a tirzepatide injection taken once a week. Separate trials reported 13.6% average weight loss with the licensed 25 mg Wegovy pill at 64 weeks and 22.5% with Mounjaro 15 mg at 72 weeks. These were not head-to-head trials and used different analyses, so the figures cannot predict which treatment will work best for you. A prescriber should consider your health, other medicines, side effects, routine and treatment preference.DailyWegovy pill routine
WeeklyMounjaro injection routine
13.6%average loss in the OASIS-4 main analysis
22.5%Mounjaro 15 mg efficacy estimate in SURMOUNT-1
Content last updated: 11 October 2026
At a Glance
1. Wegovy Pill and Mounjaro Compared
Both are prescription treatments used alongside a reduced-calorie diet and increased physical activity. Their active ingredients, dosing routines and administration are different. You can review the current Wegovy pill information and, if you are considering Mounjaro, check its doses, prices and assessment process before you buy Mounjaro online.| Feature | Wegovy pill | Mounjaro |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| Medicine class | GLP-1 receptor agonist | GIP and GLP-1 receptor agonist |
| Format | Tablet swallowed whole | Injection under the skin |
| How often | Once daily | Once weekly |
| Starting dose | 1.5 mg daily | 2.5 mg weekly |
| Highest licensed dose | 25 mg daily | 15 mg weekly |
| Food and drink | At least 8 hours fasting, then a 30-minute wait | With or without food |
| Needles | No | Yes |
The practical differenceThe pill avoids injections but needs a precise morning routine. Mounjaro avoids daily fasting instructions but requires a weekly injection and safe needle disposal.
Clinical Evidence
The OASIS-4 main analysis included outcomes after treatment discontinuation and use of other weight-management interventions. Its separate continued-treatment estimate was 16.6%. The SURMOUNT-1 figures above used an efficacy estimand that assumed participants remained on treatment. Because the analyses differ, the percentages should not be read as a direct contest.
Trial averages also include a wide range of individual responses. Some people lose more and some lose less. Dose tolerance, adherence, eating pattern, activity, starting health and time on treatment all matter. See the dedicated guides to Wegovy pill results and Mounjaro weight-loss results for more context.
2. Which Produced More Weight Loss in Trials?
There is no direct head-to-head trial of the licensed 25 mg Wegovy pill and Mounjaro. The figures below come from separate studies with different durations, participants and statistical methods. They provide context, but they do not prove how the two medicines would compare in the same person.| Treatment | Study | Reported average | Duration and analysis |
|---|---|---|---|
| Wegovy pill 25 mg | OASIS-4 | 13.6% weight loss | 64 weeks, main treatment-policy analysis |
| Mounjaro 5 mg | SURMOUNT-1 | 16.0% weight loss | 72 weeks, efficacy estimand |
| Mounjaro 10 mg | SURMOUNT-1 | 21.4% weight loss | 72 weeks, efficacy estimand |
| Mounjaro 15 mg | SURMOUNT-1 | 22.5% weight loss | 72 weeks, efficacy estimand |
Why this is not a head-to-head comparisonA fair head-to-head trial would enrol comparable participants and randomly assign them to the two treatments under the same study rules. OASIS-4 and SURMOUNT-1 were separate trials, so their results cannot establish that one medicine will work better for an individual.
Daily Routine
3. How Do the Routines Differ?
Taking the Wegovy pill
Take the tablet after fasting for at least eight hours, usually when you wake. Swallow it whole with no more than 120 mL of water, then wait at least 30 minutes before eating, drinking or taking other oral medicines. Food, extra water and a shorter wait can reduce absorption. Read the full instructions on how to take the Wegovy pill.Using Mounjaro
Mounjaro is injected once weekly on the same day, at any time and with or without meals. The KwikPen is used under the skin of the abdomen, thigh or upper arm. A new compatible needle is needed for each injection. Your dose normally increases gradually if your prescriber considers it appropriate. See the full Mounjaro dose schedule.Choose a routine you can follow correctlyIf mornings are unpredictable or you take several oral medicines when you wake, the pill routine may be difficult. If you strongly dislike needles, the tablet may be easier to maintain. Tell your prescriber what daily life actually looks like.
Suitability
A prescriber will also consider pregnancy plans, digestive conditions, gallbladder and pancreatic history, diabetes treatment, kidney function and other medicines. Do not combine the treatments or choose a dose yourself.
4. Who Might Prefer Each Treatment?
The prescribing criteria for both medicines include adults with obesity, or adults who are overweight and have at least one weight-related health condition. Meeting the basic criteria does not mean either treatment is automatically suitable.| The Wegovy pill may be more practical if… | Mounjaro may be more practical if… |
|---|---|
| You strongly prefer to avoid injections. | You prefer one treatment day each week. |
| You can reliably follow the fasting and waiting instructions. | A daily fasting routine would be difficult. |
| Your other oral medicines can be timed safely around the tablet. | You are comfortable self-injecting and disposing of needles. |
| A prescriber considers semaglutide appropriate for you. | A prescriber considers tirzepatide appropriate for you. |
Safety and Tolerability
5. How Do Side Effects Compare?
Both medicines commonly cause gastrointestinal side effects, especially nausea, diarrhoea, vomiting, constipation and abdominal symptoms while the dose increases. Mounjaro can also cause injection-site reactions. The Wegovy pill avoids needles but adds fasting, absorption and medicine-timing considerations. Separate trial percentages should not be used to promise that one treatment will be easier to tolerate. Your response may change with dose and time. Read the dedicated guides to Wegovy pill side effects and Mounjaro side effects.When to seek helpContact your prescribing team if side effects are persistent, severe or stop you drinking enough fluid. Persistent severe abdominal pain, a serious allergic reaction, sudden loss of vision or symptoms of severe dehydration need urgent medical assessment.
Doses, Switching and Cost
6. What Else Should You Compare?
Dose increases
The Wegovy pill normally increases from 1.5 mg to 4 mg, 9 mg and then 25 mg, with at least one month at each step. Mounjaro starts at 2.5 mg weekly and may increase in 2.5 mg steps after at least four weeks on the current dose. Reaching the highest dose is not the goal. The right dose is the one your prescriber considers effective and tolerable.Switching treatment
There is no licensed dose-equivalence chart between the Wegovy pill and Mounjaro. Changing treatment requires a new prescription and an individual plan. Do not overlap them or use remaining medicine to create your own transition.Price and availability
Prices can change and depend on the prescribed dose. Check the current Wegovy injection cost, Wegovy pill cost and Mounjaro cost rather than relying on an old comparison figure.Common Questions
Frequently Asked Questions
Neither is better for everyone. They contain different active ingredients and use different routines. A prescriber should assess your health, other medicines, previous treatment, side effects and preferences before deciding whether either is suitable.
Separate studies reported higher average losses with higher Mounjaro doses, but there has been no direct head-to-head trial against the licensed 25 mg Wegovy pill. The studies used different methods, so they cannot predict an individual result or prove a direct ranking.
No. There is no licensed Mounjaro tablet in the UK. The Wegovy pill contains semaglutide and works through the GLP-1 receptor. Mounjaro contains tirzepatide and works through both GIP and GLP-1 receptors. Mounjaro is supplied as a weekly injection.
The answer depends on your routine. The Wegovy pill avoids needles but needs daily fasting and a 30-minute wait. Mounjaro is weekly and can be used with or without food, but it requires self-injection.
A switch may be considered after a prescriber reviews your health, current dose, response and side effects. There is no licensed dose-equivalence chart, so do not overlap treatments or choose a starting dose yourself.
Both commonly cause digestive side effects while the dose increases. Mounjaro can cause injection-site reactions, while the pill has fasting and absorption restrictions. Separate trial rates cannot reliably predict which you will tolerate better.
Need Help Comparing Your Options?Complete a confidential online consultation. A UK prescriber will review your health, medicines, treatment history and routine before deciding whether either treatment is suitable.Start Your Weight-Loss Assessment →
References
- Wegovy tablets Summary of Product Characteristics. Licensed indication, dosing, administration, warnings and OASIS-4 results.
- Mounjaro KwikPen Summary of Product Characteristics. Licensed indication, dosing, administration, warnings and SURMOUNT-1 results.
- MHRA. First GLP-1 tablet for weight loss approved in the UK. UK approval and dosing summary for Wegovy tablets.
- NICE TA1026. Tirzepatide for managing overweight and obesity.
Medically Reviewed by Our GPhC-Registered Pharmacists
